Skip to content

Drug interactions

Insulin aspart protamine / insulin aspart + Linagliptin-metformin

Severity: Moderate

Insulin aspart protamine / insulin aspart and Linagliptin-metformin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Combining insulin with linagliptin and metformin has additive glucose-lowering effects. This is a common and intended combination but raises the risk of hypoglycemia, mainly from the insulin component.

What this interaction means in plain words

Insulin aspart protamine / insulin aspart and Linagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: High

Why it happens

Additive pharmacodynamic glucose lowering through different mechanisms.

What to do

Monitor blood glucose and consider reducing the insulin dose when starting or intensifying the oral agents. Educate the patient on recognizing hypoglycemia.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Insulin aspart protamine / insulin aspart and Linagliptin-metformin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Insulin aspart protamine / insulin aspart with Linagliptin-metformin?

MediHelp rates the interaction as moderate. Insulin aspart protamine / insulin aspart and Linagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Combining insulin with linagliptin and metformin has additive glucose-lowering effects. This is a common and intended combination but raises the risk of hypoglycemia, mainly from the insulin component.

How serious is the interaction between Insulin aspart protamine / insulin aspart and Linagliptin-metformin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and consider reducing the insulin dose when starting or intensifying the oral agents. Educate the patient on recognizing hypoglycemia.

What other medicines interact with Linagliptin-metformin?

MediHelp also lists interactions of Linagliptin-metformin with, for example, Apalutamide, Carbamazepine, Contrast media. The full list is on the Linagliptin-metformin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in